Corrigendum to "Notoginsenoside R1-Protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1-YAP/TAZ pathway in vascular smooth muscle cells" [Int. Immunopharmacol. 143 (2024) 113574].
- DOI
- 10.1016/j.intimp.2026.117312
- Published
- 2026-08-26
- Container
- Int Immunopharmacol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.intimp.2026.117312,
title = {Corrigendum to "Notoginsenoside R1-Protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1-YAP/TAZ pathway in vascular smooth muscle cells" [Int. Immunopharmacol. 143 (2024) 113574].},
author = {Cui X and Zhang L and Lin L and Hu Y and Zhang M and Sun B and Zhang Z and Lu M and Guan X and Hao J and Li Y and Li C.},
year = {2026},
journal = {Int Immunopharmacol},
doi = {10.1016/j.intimp.2026.117312},
url = {https://doi.org/10.1016/j.intimp.2026.117312}
}RIS
TY - JOUR TI - Corrigendum to "Notoginsenoside R1-Protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1-YAP/TAZ pathway in vascular smooth muscle cells" [Int. Immunopharmacol. 143 (2024) 113574]. AU - Cui X AU - Zhang L AU - Lin L AU - Hu Y AU - Zhang M AU - Sun B AU - Zhang Z AU - Lu M AU - Guan X AU - Hao J AU - Li Y AU - Li C. PY - 2026 JO - Int Immunopharmacol DO - 10.1016/j.intimp.2026.117312 UR - https://doi.org/10.1016/j.intimp.2026.117312 ER -
APA
X, C., L, Z., L, L., Y, H., M, Z., B, S., Z, Z., M, L., X, G., J, H., Y, L., & C., L. (2026). Corrigendum to "Notoginsenoside R1-Protocatechuic aldehyde reduces vascular inflammation and calcification through increasing the release of nitric oxide to inhibit TGFβR1-YAP/TAZ pathway in vascular smooth muscle cells" [Int. Immunopharmacol. 143 (2024) 113574].. Int Immunopharmacol. https://doi.org/10.1016/j.intimp.2026.117312
Source records
- europe-pmc · retrieved 2026-09-27T04:26:56.353Z